Eris Biotech

About:

Eris Biotech is a biotech company that developing hypoxia-activated prodrugs (HAPs) for the treatment of solid tumors.

Website: https://www.erisbio.com

Top Investors: Y Combinator

Description:

Eris Biotech is a biotech company that developing hypoxia-activated prodrugs (HAPs) for the treatment of solid tumors.

Total Funding Amount:

$500000

Headquarters Location:

American Fork, Utah, United States

Founded Date:

2023-01-01

Founders:

Evita Weagel, Rachel Garlick

Number of Employees:

1-10

Last Funding Date:

2024-03-01

IPO Status:

Private

Industries: